The global plant-based API market is expected to experience robust growth, with a projected value of USD 30,084.8 million in ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Scientists from McGill University have discovered how certain microbes create powerful drugs such as antibiotics and cancer ...

Researchers from Southwest Jiaotong University published the discovery of novel high affinity peptides against the protein of human DNA binding domain of FOXM1 (FOXM1-DBD) to be developed for the ...

Researchers at Penn Medicine created an innovative cancer treatment using nano-sized capsules that can target and trigger cancer cell self-destruction.

Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...

ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

In a report released today, James Molloy from Alliance Global Partners initiated coverage with a Buy rating on CNS Pharmaceuticals (CNSP – ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

The acquisition is part of a debt exchange agreement between Mr. Siokas and Cosmos Health, where the shares were exchanged for a debt of $30,000 owed to him by the company. InvestingPro subscribers ...

Purple foods, like berries, plums, eggplant, and purple rice, get their color from natural compounds called anthocyanins and ...

Cosmos Health (COSM) has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others, prostate, ...